Get started
Author

Julia Y. Tsang

Observed names: J Tsang, J. Tsang, J.-S Tsang, J.Y.S Tsang, J.Y.S. Tsang, Julia Tsang, Julia Y S Tsang, Julia Y Tsang, Julia Y. S. Tsang, Julia Y.S. Tsang, Julia YS Tsang, Julia Ys Tsang, Julia Y. S. Tsang, Tsang, J, Tsang, Julia Y.
Observed institutions: The University of Sydney, Guy's Hospital, St Thomas' Hospital, National University of Singapore, Chinese University of Hong Kong, King's College London, Guy's and St Thomas' NHS Foundation Trust, Singapore General Hospital, Royal Prince Alfred Hospital, Liverpool Hospital, The Royal Free Hospital, Hammersmith Hospital, National Institute for Health and Care Research, Prince of Wales Hospital, Chinese University of Hong Kong, Shenzhen, University College London, Imperial College London, Western Sydney University, University of Hong Kong, Medical Research Council
ORCID: 0000-0001-6612-9622
Observed ORCID: 0000-0001-6612-9622
OpenAlex ID: A5090636019
Molecular Classification of Breast Cancer
2019 · Julia Y.S. Tsang, Gary M. Tse · Advances in Anatomic Pathology · 574
In vitro–expanded donor alloantigen–specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance
2006 · Dela Golshayan, Shuiping Jiang, et al. · Blood · 312
CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+ T cells contributes to their regulatory function
2013 · Lesley Ann Smyth, Kulachelvy Ratnasothy, et al. · European Journal of Immunology · 278
PDF
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
2021 · Joshua J. Li, Julia Y. Tsang, et al. · Cancers · 181
PDF
Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
2003 · Julia Y. S. Tsang, Jian Guo Chai, et al. · Blood · 117
PDF
The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro
2007 · J. Yates, F. Rovis, et al. · International Immunology · 113
PDF
Keratin expression in breast cancers
2012 · Mu-Min Shao, Siu Ki Chan, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 111
Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers
2017 · Xia Liu, Julia Y.S. Tsang, et al. · The Oncologist · 106
PDF
PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients
2017 · Julia Y. S. Tsang, Wai-Ling Au, et al. · Breast Cancer Research and Treatment · 103
Androgen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers
2014 · Julia Y. S. Tsang, Yun-Bi Ni, et al. · Annals of Surgical Oncology · 78
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
2012 · Julia Y. S. Tsang, Yu-Hua Huang, et al. · Breast Cancer Research and Treatment · 77
GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer
2018 · Yun-Bi Ni, Julia Y. S. Tsang, et al. · Breast Cancer Research and Treatment · 75
Intercellular Transfer of MHC and Immunological Molecules: Molecular Mechanisms and Biological Significance
2007 · L.A. Smyth, B. Afzali, et al. · American Journal of Transplantation · 75
Generation and Expansion of Human CD4+CD25+ Regulatory T Cells with Indirect Allospecificity: Potential Reagents to Promote Donor-Specific Transplantation Tolerance
2006 · Shuiping Jiang, Julia Tsang, et al. · Transplantation · 73
Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment
2023 · Yuyang Li, Julia Y. Tsang, et al. · EBioMedicine · 66
PDF
Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas
2013 · Ming-Hua Luo, Yu-Hua Huang, et al. · Human Pathology · 66
Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers
2013 · S. Shafaq Mujtaba, Yun-Bi Ni, et al. · Annals of Surgical Oncology · 59
Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer
2018 · Julia Y.S. Tsang, Michelle A. Lee, et al. · EBioMedicine · 55
PDF
CD4+CD25+ T cells as immunoregulatory T cells in vitro
2002 · Jian-Guo Chai, Julia Y. S. Tsang, et al. · European Journal of Immunology · 55
Mammary phyllodes tumour: a 15-year multicentre clinical review
2017 · Michael Co, Clement Chen, et al. · Journal of Clinical Pathology · 52
CX3CL1 expression is associated with poor outcome in breast cancer patients
2013 · Julia Y. S. Tsang, Yun-Bi Ni, et al. · Breast Cancer Research and Treatment · 52
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
2010 · M Perro, J Tsang, et al. · Gene Therapy · 51
The significance of highlighting the oestrogen receptor low category in breast cancer
2020 · Ivan K. Poon, Julia Y. Tsang, et al. · British Journal of Cancer · 47
Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer
2020 · Shirley K Jamidi, Jintao Hu, et al. · Histopathology · 45
Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features
2019 · Joshua Li, Julia Y. Tsang, et al. · Annals of Surgical Oncology · 45
Works count: 134
Citation count: 4,431
H-index: 35
I10-index: 86
Year
Topic
Type